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Introduction: Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system (CNS) leading
to progressive neurological disability. Interferon β (IFNβ) represents a standard treatment for relapsing-remitting MS
and exogenous administration of IFNβ exhibits protective effects in experimentally induced CNS autoimmunity.
Also, genetic deletion of IFNβ in mice leads to an aggravation of disease symptoms in the MS model of experimental
autoimmune encephalomyelitis (EAE). However, neither the underlying mechanisms mediating the beneficial effects
nor the cellular source of IFNβ have been fully elucidated.
Results: In this report, a subpopulation of activated microglia was identified as the major producers of IFNβ in the
CNS at the peak of EAE using an IFNβ-fluorescence reporter mouse model. These IFNβ expressing microglia specifically
localized to active CNS lesions and were associated with myelin debris in demyelinated cerebellar organotypic slice
cultures (OSCs). In response to IFNβ microglia showed an enhanced capacity to phagocytose myelin in vitro and
up-regulated the expression of phagocytosis-associated genes. IFNβ treatment was further sufficient to stimulate
association of microglia with myelin debris in OSCs. Moreover, IFNβ-producing microglia mediated an enhanced
removal of myelin debris when co-transplanted onto demyelinated OSCs as compared to IFNβ non-producing microglia.
Conclusions: These data identify activated microglia as the major producers of protective IFNβ at the peak of EAE and
as orchestrators of IFNβ-induced clearance of myelin debris.
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Multiple sclerosis (MS) is an inflammatory demyelinat-
ing disease of the central nervous system (CNS). More
than 20 years ago, interferon β (IFNβ) became the first
immunomodulatory substance used in the treatment of
MS. IFNβ is currently the most commonly used therapy
for relapsing-remitting MS (RRMS), reducing relapses
and severity of disease [1,2]. Genetic ablation of IFNβ or
its receptor leads to an increased severity of experimental
autoimmune encephalomyelitis (EAE) [3,4] a mouse
model exhibiting clinical, neuropathological, and im-
munological disease manifestations of MS [5]. Conversely,
induction of endogenous IFNβ by poly (I:C) stimulation
suppresses EAE, confirming its protective role in CNS
autoimmunity [6]. Today, neither the cellular source of* Correspondence: stefanie.scheu@hhu.de
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unless otherwise stated.type I IFN in EAE nor its localization relative to respond-
ing cells is known due to a lack of sufficiently sensitive in
situ tools.
Also, the exact mechanisms underlying the protective
effects of IFNβ remain incompletely understood. Various
IFNβ-mediated modes of action have been suggested, in-
cluding (i) downregulation of matrix metalloproteinase 9
thereby reducing tissue damage and inflammation, (ii)
prevention of effector cell migration by downregulating
the adhesion molecule very late antigen-4 (VLA-4) [7,8],
(iii) downregulation of MHC II molecules on antigen
presenting cells combined with upregulation of the in-
hibitory PD-L1 and PD-L2 ligands [9,10], (iv) inhibition
of T cell proliferation [11], (v) the induction of immune
cell apoptosis [12] and (vi) most recently the induction
of FoxA1+ T regulatory cells [13]. Removal of myelin
debris has been suggested as an essential protective
mechanism ameliorating IFNγ-mediated neuroinflam-
mation by downregulating the transcription levels of
pro-inflammatory factors like TNF, IL-1β, or iNOS [14].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cacy may therefore represent a novel therapeutic approach
in the treatment of neuroinflammation as observed in MS.
Until now, however, a direct role for IFNβ in phagocytosis
of myelin or axonal debris has not been shown and the
functional consequences of microglial phagocytosis re-
main largely unexplored.
Though IFNβ was shown to delay disease progression,
adverse side effects such as depression, flu-like symp-
toms, skin reactions, and bone marrow suppression have
limited its use [15]. Also, IFNβ treatment is not always
effective, as about 30% to 50% of patients experience
breakthrough disease. One reason is production of neu-
tralizing antibodies to IFNβ resulting in reduced or
complete loss of therapeutic efficacy [16]. Moreover,
there is the risk that a long term systemic “block” of in-
flammation could affect the elicitation of immune re-
sponses required for host defense. Therefore, it is of
great interest to identify the cellular source and define
the mechanisms associated with IFNβ-mediated protec-
tion against neuroinflammation as a first step in the de-
velopment of cell-specific treatment regimes.
In this study we characterized the cell type responsible
for IFNβ production and its impact on microglia effector
functions in EAE using a yellow fluorescent protein
(YFP) IFNβ reporter mouse model, organotypic slice cul-
tures, and adult microglia cell cultures. We demonstrate
that microglia are the primary IFNβ producing cells dur-
ing the peak phase of EAE. We further show that IFNβ
induces localization of microglia in close proximity to
myelin debris and subsequently increases microglial
phagocytotic activity. These findings and the fact that
IFNβ-producing microglia orchestrated the clearance of
myelin debris in organotypic cerebellar slice cultures re-
veal a so far unknown function of IFNβ. Our data fur-
ther suggest that future IFNβ-based therapies targeting
these cells in the CNS can be developed for treatment of
demyelinating CNS disorders.
Materials and methods
Mice and EAE induction
Female C57BL/6 N mice were purchased from Charles
River. IFNβmob/mob (messenger of IFN beta: IFNβ/YFP
reporter mouse) [17], IFNβ−/− [18] and IFNAR1−/− [19]
mice were backcrossed for at least 10 generations onto
C57BL/6 N background. PLP-EGFP mice were used for
indicated organotypic slice culture experiments [20]. All
mice were housed under specific pathogen free condi-
tions in the animal research facility of the University of
Duesseldorf. Mice at 6–12 weeks of age were used for
all experiments. Active EAE was induced by tail-base
immunization with 200 μg of MOG35–55 (Biotrend) in
complete Freund's adjuvant (CFA), supplemented with
Mycobacterium tuberculosis H37RA (10 mg/ml) (DifcoLaboratories) and 200 ng pertussis toxin (Sigma) on 0d
and 2d. A control group was treated with CFA only and
200 ng pertussis toxin on 0d and 2d. Classification of
disease progression: 0 no paralysis; 0.5 partial paralysis
of tail; 1.0 paralysis of tail; 1.5 unilateral paralysis of
hind legs; 2.0 bilateral paralysis of hind legs; 2.5 bilat-
eral paralysis of hind legs with unilateral weakness of
forelegs; 3 tetraparesis (abort criteria); 4 death. All ani-
mal experiments were approved by the government of
North Rhine-Westphalia (Az.: 84–02.04.2013.A466, Az.:
8.87-50.10.34.08.241).
Organ and CNS mononuclear cell isolation
Mice were anesthetized and thereafter perfused with
50 ml ice cold PBS. For qRT PCR and flow cytometric
analysis spleen, spinal cord and brain were removed. For
flow cytometric analysis spinal cord and brain were ho-
mogenized and digested with collagenase/dispase (Roche)
followed by DNase I (Roche) digestion. CNS derived
mononuclear cells were isolated from the 30%/70% inter-
face of a Percoll gradient after centrifugation at 800 × g for
25 min at room temperature. For RNA isolation organs
were isolated after perfusion with 50 ml PBS and quick-
frozen in liquid nitrogen.
Antibodies
We used monoclonal Antibodies against murine CD11b
(M1/70), CD86 (GL-1), CD45 (104) from BD Biosciences,
CD16/CD32 (2.4G2) from eBioscience for FACS analysis.
Antibodies used for the OSC, spinal cord and brain hist-
ology: rat-MBP (1:500) from Millipore, rabbit-Iba1 (1:500)
from WAKO Chemicals, mouse-Neurofilament (NF-M)
(1:1000) from Convance Laboratories Inc., giunea pig-
GFAP (1:1000) from SYnaptic Systems, rat-CD68 (1:500)
from BioLegend, rat-Mac3 (1:500) from BioLegend, rat-
TLR3 (1:500) from BioLegend, rb-pIRF7 (1:400) from
Bioss-Antibodies and rabbit-CCR2 (1:500) from Bioss-
Antibodies and rtLAMP2 (1:400) von BioLegend. A poly-
clonal crossreacting anti-GFP antibody was purchased
from Abcam. Biotin conjugated donkey-anti-rabbit, as
well as normal sera from mouse, rat and donkey were pur-
chased from Jackson Immuno Research. All secondary
antibodies conjugated with fluorophores (Cyanine Dye
Cy2, Cy3 and Cy5) were purchased from Life Technolo-
gies and used in a dilution of 1 to 500.
Flow cytometry and cell sorting
Co-expression of indicated cell surface markers with
YFP expression was analyzed on a FACS Canto II
(Becton Dickinson). Cells were pregated as DAPI-. Iso-
lated CNS mononuclear cells or primary adult micro-
glia were sorted on a FACS Aria cell sorter (Becton
Dickinson) for CD11b and CD45 and YFP reporter al-
lele expression. RNA isolation of ex vivo sorted primary
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lation kit (Ambion Inc). RNA isolation of in vitro
sorted primary adult microglia was performed with
RNA isolation kit (Fluka).
Intracerebroventricular injection
Mice were anaesthetized with isofluran and placed in a
stereotactic frame. The skull was exposed and trepanated
for injection of 6 μg poly (I:C) (Amersham) into the lateral
ventricle. The bregma coordinates were AP: −0.3 mm,
ML: +1.0 mm, and DV −3.0 mm.
Cell culture
For primary adult microglia culture CNS mononuclear
cells were isolated from brain and spinal cord of 4–6
week old mice under sterile conditions and cultured in
VLE-DMEM (Biochrom) with 10% FCS, 50 μM β-ME
and 15% of M-CSF containing supernatant from L929
cells. The protocol was adapted from Ponomarev [21].
Cells were stimulated on d14 with 50 μg/ml poly (I:C),
6 μg/ml CpG2216 (TIB MOLBIOL), 100 ng/ml Lipo-
polysaccharide (LPS) from Salmonella minnesota R595
(List Biological Laboratories, Inc.), 1 μg/ml Pam3CSK4
(Invivogen) or 100 U/ml mouse recombinant IFNβ (R&D
Systems) for 6 h or 24 h as indicated or analysis of phago-
cytosis capacity was performed with DII-coupled myelin
isolated according to Norton and Poduslo [22].
Mouse BV2 cells [23,24] were maintained on uncoated
petri plates in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen) supplemented with Glucose (4.5 g/l),
10% FCS (Invitrogen), 20 mM GlutaMAX (Life Technolo-
gies) and penicillin/streptomycin (5 μg/ml) (Life Technolo-
gies). Media was changed every 2 days and cells were
passaged at a confluence of 80-90% performing trypsiniza-
tion (Invitrogen).
Immunofluorescence of microglial cells
Primary microglia or BV2 cells were once washed with
PBS, fixed with 4% PFA for 15 minutes and again
washed 2 times with PBS. Cells were blocked for 1 h
with 5% (v/v) horse serum (Sigma Aldrich) in 0.5% (v/v)
Triton X-100 in PBS. Primary antibodies were diluted in
2.5% (v/v) horse serum, 0.25% (v/v) Triton X-100 in PBS
and incubated overnight at 4°C. After three times wash-
ing for 5 minutes with 0.1% (v/v) Triton X-100 in PBS
the cells were incubated with fluorescent secondary anti-
bodies, diluted in 2.5% (v/v) horse serum, 0.25% (v/v)
Triton X-100 in PBS, for 1 h at RT. Cells were counter-
stained with Hoechst (Life Technology) and mounted on
glass slides with Immuno Mount (DABCOTM).
RNA isolation, cDNA synthesis and qRT-PCR
RNA was isolated with RNA isolation Kit (Fluka or
Macherey-Nagel). Purified RNA was digested with DNaseI (Roche) to remove trace contaminating genomic DNA.
An aliquot corresponding to 0.5 – 3 μg of purified RNA
was used for first-strand cDNA synthesis using Super-
script III reverse transcriptase and oligo (dT) in a final vol-
ume of 20 μl according to the manufacturer’s instruction
(Invitrogen Life Technologies). cDNA was used for subse-
quent PCR. Real-time quantification of genes was per-
formed using a SYBR Green RT-PCR assay (Applied
Biosystems, USA). Briefly, each 20 μl SYBR green reaction
consisted of 5 μl cDNA, 10 μl SYBR Green PCR-mix (2×),
1 μl forward and reverse primer (5pM) and 4 μl distilled
water. PCR was performed with the following cycling con-
ditions: 40 cycles of 10 sec at 95°C, 60 sec at 60°C and a
separate dissociation step. Specificity of the PCR product
was confirmed by examination of the dissociation reaction
plots. A distinct single peak indicated only one DNA se-
quence was amplified during the RT-PCR. The samples
were run in duplicates and the level of expression of each
gene was compared with the expression of GAPDH. Amp-
lification, detection of specific gene products and quanti-
tative analysis were performed using an “ABI 7500”
sequence detection system (Applied Biosystems, USA).
Organotypic slice cultures
Organotypic slice cultures (OSCs) were generated from
10 days old mice as described before [25]. The cerebel-
lum was cut into 400 μm thick slices using a McIllwain
tissue chopper (GaLa Instrumente). OSC were dissoci-
ated in ice-cold dissecting medium (Hank’s Balanced Salt
Solution (HBSS), Life Technologies) complemented with
penicillin/streptomycin (100 U/ml, Life Technologies),
2.5 mg/ml glucose (Sigma Aldrich) and 10 mM kynurenic
acid (Sigma Aldrich). OSCs were cultured on Millicell-
CM culture plate inserts (Millipore) in culture medium
(50% (v/v) MEM, 25% (v/v) HBSS, 25% (v/v) heat-
inactivated horse serum, 2 mM glutamine, penicillin/
streptomycin (100 U/ml) (all from Life Technologies) and
2.5 mg/ml glucose (Sigma Aldrich) for 3–5 days at 37°C in
a humidified atmosphere with 5% CO2, and then demyeli-
nated with lysolecithin (0.5 mg/ml, 16 h). After incubation
the lysolecithin containing medium was removed and
replaced with fresh medium. At this point OSCs were
used for all experiments. In some experiments OSCs
were treated with 100 U/ml mouse rIFNβ as indicated.
For the usage of PLP-EGFP slices, fluorescent images were
taken on indicated time points with an Olympus BX51
microscope at low magnification and in sterile conditions.
Histology
Brain and spinal cord were fixed with periodate-lysine-
paraformaldehyde (PLP) overnight, incubated in 10% su-
crose followed by 20% and 30% sucrose incubation steps.
Organs were frozen in TissueTek (Sakura). Endogenous
peroxidase activity and biotin were blocked. The staining
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anti-GFP antibody overnight with 0.1% Triton at 4°C.
Fluorescence was enhanced with TSA Fluorescein
(PerkinElmer) according to the manufacturer‘s in-
structions. Sections were mounted with DAPI contain-
ing Vectashield [26]. Imaging was performed on an
epifluorescence microscope (Eclipse TE 2000, Nikon) with
digital camera (CCD-1300, Vosskuehler) and overlaid
using Adobe Photoshop.
For immunocytochemistry cryo sections were stained
with luxol fast blue (solvent blue from Sigma Aldrich) for
demyelination and nuclear fast red (Sigma Aldrich) for
nuclei. Imaging was performed on a fluorescent micro-
scope (Olympus BX51) with a digital camera (Olympus
F-View II).
OSCs were washed two times in warm PBS, fixed
40 minutes in 4% paraformaldehyde (PFA) and perme-
abilized for 1 h with 1% (v/v) Triton X-100 (Sigma Al-
drich) in PBS [25]. OSCs were blocked for 2 h with 5%
(v/v) horse serum (Sigma Aldrich) in 0.5% (v/v) Triton
X-100 in PBS. Primary antibodies were diluted in 2.5%
(v/v) horse serum, 0.25% (v/v) Triton X-100 in PBS and
incubated for two days at 4°C. After three times washing
for 15 minutes with 0.1% (v/v) Triton X-100 in PBS the
OSCs were incubated with fluorescent secondary anti-
bodies, diluted in 2.5% (v/v) horse serum, 0.25% (v/v)
Triton X-100 in PBS, overnight at 4°C. OSCs were coun-
terstained with Hoechst (Life Technology) and mounted
on glass slides with Immuno Mount (DABCO™). Primary
and secondary antibodies used are described above. Im-
aging was performed on a laser scanning confocal micro-
scope (Zeiss Axiovert 200 M/LSM 510) with a digital
camera (Zeiss Axiocam) and a fluorescent microscope
(Olympus BX51) with a digital camera (Olympus F-View
II). All images were overlaid and processed with Adobe
Photoshop. For better visualization of transplanted BV-2
cells on OSCs the cells were circled using Adobe Photo-
shop software. For quantifying the MBP staining intensity
images were analyzed by ImageJ software.
Statistical analysis
All values in the figures are shown as indicated (mean ±
SEM or mean ± SD). Statistical significance was assessed
using Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).
Results
IFNβ is produced primarily by microglia during the
effector phase of EAE
To characterize the expression of IFNβ and a represen-
tative IFN-inducible gene (Isg56) in CNS autoimmunity
over a long term period we immunized C57BL/6 N mice
with MOG35–55 peptide (hereafter referred to as MOG)
and characterized gene expression for 70 days. In the in-
duction phase when clinical symptoms were still absenta significant increase in IFNβ mRNA levels was observed
in the spinal cord and the spleen. A similar increase in
IFNβ message, however, was also detected in adjuvant
only controls. In the CNS, IFNβ mRNA levels increased
steadily immediately after MOG immunization and
reached a plateau in the effector phase of EAE (around
day 14) when clinical symptoms were most severe
(Figure 1a, Additional file 1: Figure S1a and S1b).
However, during remission of clinical symptoms IFNβ
expression were maintained at high levels in the CNS.
In the spleen, after a transient increase in the induction
phase, IFNβ levels remained low throughout the course of
disease (Figure 1a, Additional file 1: Figure S1a). Overall
Isg56 expression levels paralleled IFNβ expression levels
in the CNS. In the spleen, no significant induction of
Isg56 expression could be observed indicating that the
functional effects of IFNβ were mainly found in the CNS
by its direct activation of CNS resident cells or of circulat-
ing cells infiltrating the CNS (Figure 1a). To determine
the cellular source of IFNβ we sorted mononuclear cells
isolated from the spinal cord of MOG-immunized C57BL/
6 N mice at the peak phase of EAE according to CD45
and CD11b expression. The vast majority of IFNβ mRNA
was found in the CD45int CD11b+ cell fraction comprising
mainly microglia. Low levels of IFNβ mRNA were also de-
tected in CD45high CD11b+ immigrating myeloid cells. In
CD45+ CD11b− lymphocytes IFNβ expression remained
near the detection limit (Figure 1b). A similar expression
pattern of IFNβ mRNA was identified in mononuclear cell
subsets from the brain of MOG-immunized mice, al-
though at lower mRNA levels (Additional file 1: Figure
S1c). To further analyze the intrinsic ability of microglia
to produce IFNβ, we cultured primary adult microglia
from wildtype (WT) and IFNβ/YFP knock-in reporter
(IFNβmob/mob) mice [17] and stimulated them with the
pathogen associated molecular compounds poly (I:C),
CpG2216, LPS and Pam3CSK4 (Additional file 2: Figure
S2). From these tested stimuli only poly (I:C) induced sig-
nificant IFNβ expression. Up to 10% of IFNβmob/mob
microglia exhibited IFNβ/YFP expression (Figure 1c,
Additional file 2: Figure S2a). Quantitative RT-PCR
analyses of FACS-sorted IFNβ-producing primary adult
microglia demonstrated only slightly increased MDA-5
and RIG-I mRNA levels when compared to IFNβ non-
producers indicating gene expression for intracellular
nucleic acid sensing pathways in microglia in general
(Figure 1f ). Immunofluorescence analysis verified co-
expression of the microglial marker Iba1 with TLR3 in
IFNβ/YFP+ primary microglia cells generated from
IFNβmob/mob mice further demonstrating microglia express
pattern recognition receptors for poly (I:C) (Figure 1d and
e). We therefore used in vivo stimulation with poly (I:C) to
initially characterize IFNβ-producing cells in the CNS in
response to a strong and local IFNβ inducing stimulus. For
Figure 1 (See legend on next page.)
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Figure 1 IFNβ is predominantly produced by microglia during the effector phase of EAE. a EAE was induced in C57BL/6 N mice by
immunization with 200 μg MOG35–55 peptide. Pertussis toxin was applied i.p. on d0 and d2. Spleen and spinal cord were isolated at indicated time
points after immunization. Relative mRNA expression levels for IFNβ (left) and Isg56 (right) were determined by qRT-PCR. Data are pooled from two
independent experiments. n = 6–7. b On d17 after EAE induction mononuclear cells from the spinal cord of C57BL/6 N mice were sorted for CD45 and
CD11b expression. Relative mRNA expression of IFNβ was determined by qRT-PCR in the indicated cell populations. c Primary adult microglia cultures
were generated from WT and IFNβmob/mob mice and stimulated with poly (I:C) for 24 h. IFNβ/YFP expression was analyzed by flow cytometry. d and
e Immunofluorescent stainings of primary adult microglia treated as in (c). Cells were stained with anti-Iba1 (d) or anti-TLR3 (e) and for YFP
for fluorescent microscopy. Scale bar represents 50 μm. f Primary adult microglia from IFNβmob/mob mice were stimulated as in (c) and sorted
for CD45+ CD11b+ IFNβ/YFP+ vs. CD45+ CD11b+ IFNβ/YFP− expression. The relative mRNA expression of RIG-I and MDA-5 was determined by qRT-
PCR. g On d17 after immunization the phenotype of IFNβ/YFP expressing cells from the spinal cord of WT and IFNβmob/mob mice was determined for
CD45 and CD11b by flow cytometry. h Quantification of IFNβ/YFP+ cells isolated at d17 after immunization from the spinal cord of IFNβmob/mob mice.
Shown is one representative experiment out of 3 independent experiments. i Representative dot blot shows an overlay of CD45 and CD11b expression
of IFNβ/YFP+ (red) and IFNβ/YFP− (grey) cells in the spinal cord of IFNβmob/mob mice on d17 after immunization. Error bars represent SEM.
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was performed on IFNβmob/mob mice. Here, CD45int
CD11b+ cells representing microglia were identified as the
main producers of IFNβ/YFP in the CNS by flow cytome-
try (Additional file 3: Figure S3a and S3b). In immunohis-
tology IFNβ/YFP expressing cells showed a microglia-like
morphology and localized in periventricular CNS regions
(Additional file 3: Figure S3c). Next, we determined the
identity of IFNβ/YFP expressing cells in CNS autoimmun-
ity. No significant differences were observed in the disease
course of IFNβmob/mob vs. WT mice (data not shown). Flow
cytometric analysis of mononuclear cells isolated from the
spinal cord and brain of IFNβmob/mob mice at the peak of
disease (17 days after MOG-immunization) showed inter-
mediate CD45 and high CD11b expression on more than
80% of IFNβ/YFP+ cells (Figure 1g–i, Additional file 4:
Figure S4). Thus, the majority of endogenous IFNβ pro-
ducing cells in the CNS during EAE were classified as





Figure 2 IFNβ/YFP producing cells localize to active lesions in the CN
was isolated from IFNβmob/mob mice. Histological analysis of lesions in the
were stained with luxol fast blue for the detection of demyelination and n
cellular infiltrates. gm: grey matter. wm: white matter. Scale bar represents
cord of MOG-immunized IFNβmob/mob mice at d17. IFNβ/YFP+ cells were st
the area of cell infiltrates indicating lesions. Scale bar represents 50 μm.expression is restricted to a total of about 400 cells
within the spinal cord and less than 50 cells within the
brain of MOG-immunized mice (Figure 1h, Additional
file 4: Figure S4c). No IFNβ/YFP expression was detect-
able in mononuclear cells from the spinal cord of naïve
IFNβmob/mob mice (Additional file 4: Figure S4d and
S4e). These findings demonstrate that during the EAE
effector phase IFNβ is expressed in the CNS primarily
by a low frequent subpopulation of microglia.
IFNβ/YFP producing cells are located within active lesions
in the CNS at the peak of disease
To characterize the anatomical localization of IFNβ pro-
ducing cells within the CNS during autoimmunity we
performed histological analyses of the spinal cord of
IFNβmob/mob mice 17 days after MOG immunization. At
this time point, active lesions could be observed within
the grey but more prominently within the white matter
of the spinal cord (Figure 2a). Nuclear fast red-positiveFP
S at the peak of disease. a On day 17 after EAE induction spinal cord
spinal cord of IFNβmob/mob mice at peak disease. Spinal cord sections
uclear fast red for visualization of cellular infiltrates. Arrows indicate
200 μm. b IFNβ/YFP producing cells localize to lesions in the spinal
ained with a YFP-crossreacting anti-GFP antibody. Dashed lines mark
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sites as determined by luxol fast blue staining (Figure 2a).
To identify IFNβ producing cells in situ spinal cord sections
of IFNβmob/mob mice were stained for YFP and analyzed by
confocal microscopy. IFNβ/YFP signals in cellular bodies
and their processes were predominantly detected in spinal
cord areas containing high numbers of infiltrating cells
underscoring that IFNβ-producing cells accumulate in ac-
tive lesions of the CNS during EAE (Figure 2b).
Microglia but not astrocytes or neurons are the source of
IFNβ production in situ
Next, we determined whether non-hematopoietic CNS
cells, not detectable in the flow cytometric analyses, con-
tribute to IFNβ production during the inflammatory de-
myelinating response of the CNS. For this, histological
analyses of cerebellar organotypic slice cultures (OSCs)
harvested from 10 days old IFNβmob/mob mice wereYFP GFAP DNA
YFP CD68
YFP Iba1 DNA







Figure 3 Microglia but not astrocytes or neurons are the primary sourc
organotypic cerebellar slice cultures (OSCs) for co-expression of IFNβ/YFP and
and stimulated with 50 μg/ml poly (I:C) for 24 h. OSCs were stained for Iba1 (
IFNβ/YFP. Scale bars represent 25 μm. g and h EAE was induced by immuniza
clinical score >2 were sacrificed at d17 and processed for histological analysis
TLR3 (h). Scale bars represent 25 μm. i Immunofluorescent analysis shows IFN
enriched areas in OSCs. OSCs were prepared and stimulated as described aboperformed. OSCs were stimulated with poly (I:C) to in-
duce IFNβ production and stained for the microglia
marker Iba1, the astrocyte marker glial fibrillary acidic
protein (GFAP) and the neuronal marker neurofilament-
medium (NF-M). IFNβ/YFP immunoreactivity co-local-
ized exclusively with Iba1 but not with GFAP or NF-M
indicating that primarily microglia expressed IFNβ dur-
ing immune activation in situ (Figure 3a-c). IFNβ/YFP
positive cells further co-expressed the phagocytic
marker CD68 (Figure 3d) and the microglia activation
marker Mac3 (Figure 3e) as well as the pattern recogni-
tion receptor TLR3 (Figure 3f ). Histological analysis of
spinal cord lesions from EAE-induced IFNβmob/mob
mice at peak of disease revealed that only a small sub-
set of IFNβ/YFP+ cells co-stained positive for CCR2,
while the majority of IFNβ-expressing cells was negative
for this macrophage/myeloid marker (Figure 3g). Finally,






e of IFNβ production in situ. a-f Immunofluorescent analysis of
different cell markers. OSCs were prepared as described in the methods
a), GFAP (b), NF-M (c), CD68 (d), Mac3 (e) and TLR3 (f) together with
tion with 200 μg MOG35–55 peptide in IFNβmob/mob mice. Animals with a
. Shown are representative spinal cord lesions stained for CCR2 (g) and
β/YFP-expressing microglia in close association with myelin debris
ve and stained for MBP and IFNβ/YFP. Scale bar represents 25 μm.
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tive for TLR3 (Figure 3h). Using confocal microscopy we
found that IFNβ/YFP+ cells aggregated in close proximity
to areas with a high content of myelin debris caused by
spontaneous demyelination due to mechanical stress dur-
ing cerebellar slice preparation (Figure 3i). These results
point towards a possible functional role of IFNβ/YFP pro-
ducing cells within demyelinated sites in the CNS.
IFNβ enhances microglia association with myelin debris
and their phagocytic activity
Phagocytosis by microglia is a cellular process to clear
myelin debris in CNS autoimmunity [27]. To investigate
whether IFNβ affected microglia association with myelin
debris and phagocytotic capacity we utilized an ex vivo
transplantation approach of IFNβ treated microglia onto
demyelinated OSCs. To this aim microglia were treated
with recombinant IFNβ (rIFNβ), CMTMR labeled and
co-transferred together with untreated DiD labeled cells
at a 1:1 ratio onto demyelinated OSCs prepared from PLP-
EGFP mice [20,28]. Thus, migration of IFNβ-stimulated
versus untreated control microglia could be monitored on
a single viable OSC together with GFP-tagged myelin debris
structures. Demyelination occurred broadly on the OSC
after the lysophosphatidylcholin (LPC) treatment, without
harming the neuronal structures (Additional file 5: Figure
S5a). Quantification of microglial cells that localized within
myelin debris containing areas 1 h and 4 h after transplant-
ation revealed a significantly increased accumulation of
IFNβ treated microglia at these sites (Figure 4a). This spe-
cific migratory pattern was also observed in BV2 microglia
cells upon treatment with IFNβ (Additional file 5: Figure
S5b and S5c). These data indicate that IFNβ promotes the
localization of microglia to demyelinated CNS sites.
Next, we examined whether IFNβ activates the phago-
cytic machinery in microglia cells. For this, expression of
surface receptors and intracellular proteins involved in
phagocytosis and phagosome maturation were assessed
in WT, IFNβ−/− or IFNAR1−/− primary microglia as well
as the microglia derived, immortalized cell line BV2.
Multiple phagocytosis associated genes were markedly
upregulated in WT microglia in response to IFNβ
(Figure 4b, Additional file 5: Figure S5d and S5e),
among those, the sensor molecules complement receptor
3 (CR3), signal-regulatory protein alpha (SIRPα) and Fc
gamma Receptor 3 (FcγR3), shown to be directly involved
in myelin phagocytosis in microglia and macrophages
[29,30]. In addition, IFNβ upregulated microglial expres-
sion of molecules functionally involved in the general
phagocytic machinery like macrophage scavenger receptor
1 (MSR1), CD68 and milk fat globule-EGF factor 8 (Mfg-
E8) [31,32]. Furthermore, lysosome-associated membrane
protein (LAMP) 1 and LAMP2 expression, both import-
ant for phagosome assembly were enhanced in responseto IFNβ [33]. MBP positive vesicular structures could be
observed within IFNβ-activated, LAMP2+ primary
microglia indicating active phagocytosis (Additional file 5:
Figure S5f). The fact that most phagocytosis associated
genes and Isg56 were also upregulated in IFNβ−/− micro-
glia indicated a limited contribution of endogenously pro-
duced IFNβ to this gene activation (Figure 4b, Additional
file 5: Figure S5d and S5g). We also verified the induction
of Isg56 gene expression in WT and IFNβ−/− microglia
(Additional file 5: Figure S5g). None of these genes were
found to be upregulated in IFNAR1−/− microglia verifying
the specific effect of IFNβ (Figure 4b).
We further studied whether IFNβ affected the capacity
of microglia to specifically phagocytose myelin debris.
For this microglia cultures from adult WT, IFNβ−/− or
IFNAR1−/− mice and BV2 cells were treated with recom-
binant IFNβ (rIFNβ) or left untreated and incubated
with DII-fluorescent labeled myelin debris for measure-
ment of phagocytosis efficiency by flow cytometry. WT
and IFNβ−/− microglia as well as BV2 microglia phagocy-
tosed myelin debris more efficiently following treatment
with IFNβ (Figure 4c and d, Additional file 5: Figure S5h
and S5i). In contrast, IFNAR1−/− microglia did not exhibit
increased phagocytotic rates of myelin debris (Figure 4c
and d). These data indicate that IFNβ and IFNAR1-
mediated signaling is required to stimulate microglial
phagocytosis of myelin debris.
To investigate whether IFNβ would also induce phago-
cytosis in the ex vivo cerebellar slice culture model we
used the PLP-EGFP reporter mouse model to monitor
the clearance of myelin debris in situ [20]. Thus, we in-
duced demyelination in OSCs from PLP-GFP mice with
LPC and treated these cultures with rIFNβ (Figure 4e).
By using PLP-EGFP OSCs it was possible to measure the
myelin content in the same living slice culture before
and after the treatment. The myelin debris content was
significantly decreased by rIFNβ as visualized by reduced
EGFP-PLP signal in slices after 24 h treatment as com-
pared to the PBS-treated demyelinated control cultures
(Figure 4f and g). To verify the IFNβ specific effects in
this model we prepared OSCs from WT, IFNβ−/− and
IFNAR1−/− mice, induced demyelination with LPC and
stimulated them with rIFNβ (Figure 4e). The myelin
debris pattern was scored using an earlier established
method (Additional file 6: Figure S6) [34]. This revealed
that WT and IFNβ−/− slice cultures stimulated by rIFNβ
showed significantly less myelin debris than untreated
OSCs (Figure 4h and i). IFNAR1−/− OSCs exhibited no
increase in the removal of myelin debris in response to
rIFNβ, providing additional evidence that IFNβ-
dependent mechanisms drive myelin debris removal.
In a complementary approach we investigated whether
endogenously produced IFNβ also affects removal of
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Figure 4 IFNβ enhances microglia association with myelin debris and phagocytotic activity. a Co-cultures of sorted primary adult microglia
with demyelinated OSCs. Microglia from C57BL/6 N mice treated with rIFNβ and labeled with CMTMR (red) and untreated DiD-labeled (blue) microglia
were mixed 1:1 and co-transferred onto LPC-demyelinated OSCs (n = 16) from PLP-EGFP mice. For better visualization transplanted cells were marked
using Adobe Photoshop software. Diagrams show percentages of rIFNβ-treated (red) and control (blue) microglia associated with myelin debris. b
Expression of phagocytosis associated genes in WT, IFNβ−/− and IFNAR1−/− primary adult microglia after stimulation with rIFNβ (6 h). n = 2-4. c WT,
IFNβ−/− and IFNAR1−/− primary adult microglia were left untreated or stimulated with rIFNβ (24 h). DII-labeled myelin was added for the last hour of
stimulation. Uptake of myelin was quantified by flow cytometry. d Quantification of phagocytosis activity measured in (c) (n = 4–7). e Experimental
setup for analysis of myelin phagocytosis in OSCs (f,g). OSCs were LPC-demyelinated, treated with rIFNβ or PBS (24 h), and analysed for myelin debris
content. DIV, Days In Vitro. f OSCs from PLP-EGFP mice treated as in (e) were imaged. g PLP-EGFP-intensity was analyzed by ImageJ software.
(n = 16–22). h OSCs from WT, IFNβ−/− and IFNAR1−/− mice, cultured for 3 days before LPC-demyelination were treated with rIFNβ (24 h) or left
untreated and stained for MBP. i Quantification of myelin debris in OSCs from WT, IFNβ−/− and IFNAR1−/− mice after rIFNβ treatment. Scoring
as described in Additional file 6: Figure S6. (n = 3-4). j Confocal Z-stack image from a phagocytic microglia in an WT OSC after poly (I:C) treatment and
demyelination. Arrows indicate internalized myelin. Error bars represent SEM (a,b,g,i) and SD (d). Scale bars represent 10 μm (j), 100 μm (a,h), 1 mm (f).
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jected to LPC-induced demyelination. We found a sig-
nificantly higher intensity of myelin debris in OSCs of
IFNβ−/− compared to WT slices which further under-
scored that IFNβ is functionally involved in the clear-
ance of myelin debris (Additional file 5: Figure S5j and
S5k). Myelin debris was detected within the cytoplasm
of Iba1+ microglia cells in LPC-treated OSCs by con-
focal microscopy (Figure 4j). This points to an uptake
of myelin debris by microglia induced by IFNβ.
Myelin debris accumulation in the CNS is increased in EAE
in the absence of IFNβ or its receptor
According to our data, IFNβ-producing cells are local-
ized in active lesions of the inflamed CNS and phago-
cytic potential of primary adult microglia was enhanced
after stimulation with rIFNβ in vitro. To assess the in vivo
relevance of these findings, we analyzed brain sections
and visualized myelin debris accumulation in MOG-EAE
induced mice. The majority of lesion infiltrating cells were
positive for CCR2 and Mac3 (Figure 5a). To identify the
distribution of microglia in active cerebellar lesions and to
investigate the myelin debris content we stained brain sec-
tions of WT, IFNβ−/− or IFNAR1−/− mice for Iba1 and
MBP at peak disease (Figure 5b). As assessed by fluores-
cence microscopy activated microglia characterized by
their amoeboid morphology were present in active lesions
in close proximity with granular myelin debris. Enhanced
amounts of granular myelin debris were found in lesions
of IFNβ−/− and IFNAR1−/− as compared to WT mice
where myelin appears more evenly distributed. These re-
sults indicate that a lack of IFNβ production or the type I
IFN signaling pathway leads to increased myelin debris
amounts in active lesions of CNS tissue.
IFNβ-producing microglia act as orchestrators of myelin
debris removal
Our findings so far indicate that on the one hand micro-
glia produce IFNβ in CNS autoimmunity while on the
other hand IFNβ potently induces removal of myelindebris in OSCs as well as CNS lesions in the EAE model.
Thus, we wanted to clarify whether microglia additional
to their phagocytotic capacity are the relevant orches-
trators of IFNβ mediated effects in myelin debris re-
moval in vivo. In primary microglia cell cultures we
observed that multiple cells positive for phosphorylated
IRF7 localize in close proximity to single IFNβ pro-
ducers in Mac3+ cell accumulations indicating promis-
cuous activation of IFNAR signalling in neighboring
cells (Figure 6a). To investigate whether IFNβ-
producing microglia harbor the capacity to control
clearance of myelin debris in the CNS we transplanted
IFNβ-producing or non-producing microglia onto cere-
bellar slice cultures (Figure 6b). To this end primary
microglia cells from adult IFNβmob/mob mice were stim-
ulated with poly (I:C) and FACS sorted into IFNβ/YFP-
producing versus IFNβ/YFP non-producing cells. The
separated microglia populations were labeled with DiD
and transplanted onto LPC-demyelinated OSCs isolated
from WT, IFNβ−/− or IFNAR1−/− mice. DiD transplanted
microglia could be visualized embedded within the popu-
lation of resident microglia of the OSCs (Figure 6c). To
quantify myelin debris surrounding transplanted microglia
in demyelinated areas histological staining for MBP was
performed. As shown in a representative image of slice
co-cultures, IFNβ/YFP+ microglia integrated in demye-
linated regions and associated with affected myelin
structures (Figure 6d). Quantitative analysis revealed a
significantly decreased intensity of MBP debris in areas
proximal to IFNβ/YFP+ microglia as compared to
IFNβ/YFP− microglia on WT or IFNβ−/− slice cultures
(Figure 6e). In contrast, no difference in MBP intensity
was measurable between areas proximal to IFNβ/YFP+
vs. IFNβ/YFP− microglia transplanted onto IFNAR1−/−
slice cultures. Thus IFNβ-expressing microglia can act
as inducer cells for clearance of myelin debris. This
process is mediated via type I IFN receptor signalling.
Taken together, these data demonstrate that IFNβ pro-
ducing microglia exhibit an enhanced capacity to in-
duce phagocytosis of myelin debris highlighting their
Figure 5 Myelin debris accumulation in the CNS is increased in EAE in the absence of IFNβ or its receptor. EAE was induced by immunization
with 200 μg MOG35–55 peptide in WT, IFNβ−/− and IFNAR1−/− mice. Animals of each genotype with an equivalent clinical score (>2) were sacrificed at
d17. Shown are representative brain sections stained for CCR2 and Mac3 (a) and Iba1 and MBP (b) together with DAPI using fluorescence microscopy.
Arrows mark accumulated myelin debris in close proximity to activated microglia and arrow heads mark myelin debris in the lesion structure. Scale bar
represents 25 μm (a) and 50 μm (b).
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of myelin debris in the CNS.
Discussion
The high relevance of IFNβ in the therapy of MS and its
pleiotropic protective effects in mice and men are irrevoc-
able. Here we identified the so far ill-defined IFNβ produ-
cing cells in CNS autoimmunity as primarily microglia in
active lesions within the CNS. We further demonstrate
that these microglia orchestrate phagocytosis of myelin
debris in a process mediated by and dependent on IFNβ.
Our time course analyses showed that IFNβ produc-
tion and the expression of the IFN-inducible Isg56 in
the CNS starts with the onset of clinical symptoms and
increases in parallel with the disease score of MOG-
induced EAE. These findings extend previous data
showing that IFNβ is produced at the peak of EAE ex-
clusively in the CNS [3]. In peripheral lymphoid organs,
however, we found IFNβ upregulated early after MOG-
immunization and decreased afterwards. This initial expres-
sion of IFNβ is also observed when CFA is administered in
the absence of MOG and is therefore the result of theimmuno-adjuvant containing heat-inactivated M. tubercu-
losis that induces a strong innate immune response. Plas-
macytoid dendritic cells have been shown to be responsible
for this early produced IFNβ [35] that exacerbates the clin-
ical course of EAE presumably via contributing to the
priming of encephalitogenic T cells. Expression of
IFNα/β in the effector phase of disease instead was sug-
gested to mediate protective effects by acting directly
on myeloid cells [3].
We identified microglia, but not astrocytes or neurons
as the major cellular source of IFNβ in the CNS at peak
EAE. The identity of IFNβ producing cells in the course
of EAE has been a long-standing topic of debate. In gen-
eral, different cell types, mainly professional antigen pre-
senting cells, are capable of producing IFNβ in the
context of immune activation. Plasmacytoid and classical
dendritic cells are capable of IFNβ production after TLR9-
and TLR3/MDA5-stimulation, respectively [17,36]. During
viral infections in the CNS also neurons have been shown
to produce IFNβ [37]. In vitro murine neurons as well as
microglia produced IFNβ after poly (I:C) stimulation
[38,39]. Other brain resident cells reported to produce
Figure 6 IFNβ-producing microglia act as orchestrators of myelin debris removal. a Representative immunofluorescent stainings of primary
adult microglia prepared as described above. Cells were co-stained for YFP, pIRF7, and Mac3 together with DAPI. Mac3 and pIRF7 were depicted on
separate images for better visualization. Scale bar represents 50 μm. b Scheme of the experimental setup. Primary microglia cells were isolated from
IFNβmob/mob mice and treated with poly (I:C) for 24 h. Stimulated microglia (CD11b and CD45) were sorted by flow cytometry for YFP and labeled with
DiD. For co-culture experiments YFP-positive and YFP-negative sorted microglia cells were transplanted onto demyelinated cerebellar slice
cultures isolated from WT, IFNβ−/− and IFNAR1−/− mice. Demyelination was performed one day prior of transplantation with LPC. c Representative
image of transplanted DiD labeled microglia in close vicinity to endogenous microglia in the OSC. Scale bar represents 50 μm. d Representative images
of YFP-negative (left) and YFP-positive (right) sorted microglia after transplantation onto demyelinated OSCs. Scale bar represents 50 μm. e Diagram
shows intensity of immunostaining for MBP in OSCs from WT, IFNβ−/− and IFNAR1−/− mice transplanted with YFP-negative (white bars) and YFP-
positive (black bars) microglia. The quantification of myelin debris in areas surrounding transplanted cells in demyelinated areas was performed by
histological analysis of MBP intensity in 0.01 mm2 with ImageJ software (n = 4 for WT; n = 3 for IFNβ−/− and n = 3 for IFNAR1−/−). Data shown as mean
+ SEM. Statistical significance was determined by Student’s t test with *p < 0.05.
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Goutières Syndrome, a rare neurodevelopmental disorder
[40]. In MS IFNβ production was detected in active le-
sions in cells defined as macrophages and astrocytes based
on their morphology [41]. Also, based on morphological
studies it was suggested earlier that IFNβ may be pro-
duced by ramified microglia or infiltrating cells in EAE
[4]. Our study defines activated microglia as the promin-
ent IFNβ-producing cell type in the CNS as characterized
by an intermediate CD45 and high Iba1 expression as well
as a hypermorphic-rounded morphology in the IFNβ/YFP
fluorescence reporter mouse model [42-44]. It has been
suggested that an activated CD45high CD11b+ microglia
subset with the capacity to differentiate into macrophages
or dendritic-like cells plays an active role in the pathogen-
esis of EAE [21,45]. However, our data indicate that IFNβ-
expressing microglia did not acquire a CD45high CD11b+
phenotype during MOG-EAE excluding that they pheno-
typically and functionally resemble the earlier described
subset. The fact that in our study IFNβ production was
identified in microglia not only during EAE but also after
intrathecal injection of the molecular pathogen compound
poly (I:C) points to a specialized function of these CNSresident phagocytes to produce type I IFNs. Of note, at
early timepoints after intrathecal poly (I:C) application
Khorooshi et al. describe a quick mobilization of IFNβ
producing myeloid cells from the periphery into the CNS
(personal communication). The discrepancies between
these two studies could be explained by the different
modes intrathecal poly (I:C) application was used (intra-
cerebroventricular vs. intracisterna magna), that may
cause induction of divergent chemokine patterns driving
leukocyte infiltration. However, in this report, also micro-
glia were shown to contribute to IFNβ production. The
IFNβ expression capacity by these cells is in line with our
findings on IFNβ production by microglia in CNS auto-
immunity without prior poly (I:C) stimulation. We could
show that IFNβ-producing microglia localized in the prox-
imity of myelin lesions and exhibit a superior capacity to
induce phagocytosis of myelin debris in surrounding cells.
It is yet unclear which chemotactic factors guide posi-
tioning of microglia into areas of demyelination in CNS
autoimmunity. It has been suggested that astrocytes dir-
ect migration and activation of microglia and macro-
phages in demyelinating lesions via expression of CCL2
and CXCL10. Correspondingly microglia and immigrating
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and CCR2 in MS lesions [46]. Recent elegant data defined
CCR2 as a selective marker for infiltrating macrophages in
the inflamed CNS [47-49]. Our data do not rule out that
immigrating myeloid cells contribute to IFNβ production
as indicated by (i) detection of IFNβ mRNA in peripheral
tissues early after immunization, (ii) CCR2 expression
in a subset of IFNβ/YFP+ cells in CNS lesions, and (iii)
direct flow cytometric detection of CD45high IFNβ/
YFP+ cells.
The most important finding of our study is that stra-
tegically positioned IFNβ producing microglia within ac-
tive CNS lesions exhibit a superior capacity to induce
myelin debris removal in surrounding tissue phagocytes.
Effective clearance of myelin debris is a critical step in
the pathogenesis of MS as well as EAE. While microglia
have been attributed important roles in the inflamma-
tory response during infections and CNS autoimmunity
[50] it is still a matter of debate whether microglia repre-
sent efficient phagocytes in the CNS [27]. Here we could
show that phagocytosis of myelin debris by microglia
was dependent on IFNβ and its receptor IFNAR1. These
findings are supported by recent studies showing that
in vitro microglia deficient in TIR domain containing
adapter inducing interferon beta (TRIF)−/− less effectively
cleared axonal debris. These microglia further exhibited an
increased threshold for activation of interferon-regulated
genes, suggesting that IFNβ may upregulate phagocytic ac-
tivity [51]. In contrast to this, earlier studies suggested that
IFNβ suppresses the phagocytosis of myelin debris in vitro
[3]. In these studies, phagocytic activity, however, was
tested in peritoneal macrophages or CD11b+ cells in
the CNS not differentiating between resident microglia
and immigrated macrophages from the periphery. The
discrepancy to our data can therefore be explained by
differences in the phagocytic activity of microglia and
macrophages [52].
The EAE in vivo model exhibits a high variability in dis-
ease severity and in the localization of CNS lesions be-
tween individual animals. Also the suppressive effect of
IFNβ and IFNAR mediated signalling on EAE development
might reduce demyelination as well as microglia activation
[3,4], and Khorooshi et al., personal communication. To
eliminate this variability, the unwanted bias and the influ-
ence of peripheral immune responses, we used the model
of LPC-induced demyelination on OSCs [28] allowing a
reproducible and controlled evaluation of IFNβ and
microglia mediated effects. IFNβ expressing microglia
specifically localized to demyelinated regions in OSCs
and further showed lower amounts of myelin debris in
their direct proximity in comparison to IFNβ non-
producers indicative of a more efficient myelin debris
removal. This phagocytosis activating effect was con-
firmed by transfer of IFNβ/YFP producing microglia ondemyelinated WT as well as IFNβ−/− OSCs but was not
observed on IFNAR1 deficient OSCs. These data point
towards a pivotal function of IFNβ producing microglia
in the orchestration of phagocytosis of myelin debris by
not only neighboring microglia but also immigrating
phagocytes in CNS autoimmunity. It remains to be
shown, however, whether the effects observed in EAE
can be translated into human MS. While myelin phago-
cytosis has been suggested to contribute to damage
processes in MS by the associated oxidative burst, a
number of studies have shown beneficial effects for the
effective clearing of myelin debris [27]. Phagocytosis of
myelin debris by activated microglia was observed in
MS lesions [53] and was essential to promote regener-
ation [54]. Recently, overexpression of the phagocytosis
triggering receptor TREM2 was shown to reduce the se-
verity of clinical symptoms in EAE [55]. Myelin debris was
shown to impair remyelination by inhibiting differenti-
ation as well as the recruitment of oligodendrocyte pre-
cursor cells after injury [56]. Also, myelin directly
inhibited axonal re-growth as it contains several growth
inhibitory molecules such as Nogo A [57]. A secondary
protective effect of IFNβ-activated myelin phagocytosis
might be the induction of a regulatory type of microglia
resembling M2 macrophages [58].Conclusions
A number of studies indicate that myelin clearance in
the CNS after demyelination is protective or ameliorates
disease symptoms in EAE and MS. Here, we identify
microglia as orchestrators of myelin phagocytosis via
production of the protective IFNβ at the peak of CNS
autoimmunity. Our findings represent novel insights
into the in vivo functions of microglia-derived IFNβ and
the feasibility of novel therapeutic approaches for MS
specifically targeting CNS microglia.Additional files
Additional file 1: Figure S1. Clinical score of C57BL/6 N mice after
MOG immunization and IFNβ expression in the CNS. a EAE was induced
in C57BL/6 N mice by immunization with MOG35–55 (200 μg). Pertussis
toxin was applied i.p. on d0 and d2. Data represent 6 – 15 animals for
each time point. Error bars represent SEM. b C57BL/6 N mice were treated
with CFA only. Pertussis toxin was applied i.p. on d0 and d2. The spleen and
the spinal cord were isolated at indicated time points after CFA
immunization. Relative mRNA expression levels of IFNβ were determined by
qRT-PCR. Error bars represent SD. n = 3–4. c IFNβ expression on d17 after
MOG-immunization. Shown is IFNβ mRNA expression of sorted cell
populations isolated from the brain of C57BL/6 N mice according to
their CD45 and CD11b expression. The relative mRNA expression of
IFNβ was determined by qRT-PCR.
Additional file 2: Figure S2. Induction of IFNβ production in primary
adult microglia by molecular pathogen compounds. a and b Primary
adult microglia cultures were generated from WT and IFNβmob/mob mice.
On d14 microglial cells were stimulated with 50 μg/ml poly (I:C), 6 μg/ml
Kocur et al. Acta Neuropathologica Communications  (2015) 3:20 Page 14 of 16CpG2216, 100 ng/ml LPS or 1 μg/ml Pam3CSK4 for 24 h. IFNβ/YFP (a)
and CD86 (b) expression was analyzed by flow cytometry.
Additional file 3: Figure S3. IFNβ expression in the CNS after intrathecal
poly (I:C) stimulation. WT and IFNβmob/mob mice were injected intrathecally
with 6 μg poly (I:C). a IFNβ/YFP expression in the brain-isolated
mononuclear cells was determined by flow cytometry 24 h after
stimulation. DAPI− cells were gated for CD45, CD11b and IFNβ/YFP
expression. b Representative dot blot shows an overlay of CD45 and
CD11b expression of IFNβ/YFP+ (red) and IFNβ/YFP− (grey) cells isolated from
the brain of IFNβmob/mob mice on d17 after immunization. c Localization of
IFNβ/YFP expressing cells was determined by immunofluorescence of brain
slices of IFNβmob/mob mice. IFNβ/YFP was stained with a YFP-crossreacting
anti-GFP antibody. Nuclei were stained with DAPI (grey) (10-fold
magnification).
Additional file 4: Figure S4. Microglia express IFNβ/YFP in MOG-EAE in
the brain. a EAE was induced in WT and IFNβmob/mob mice with 200 μg
MOG35–55 peptide. On d17 after immunization the phenotype of IFNβ/YFP
expressing cells from the brain was determined in DAPI− cells stained for
CD45 and CD11b by flow cytometry. b Representative dot blot shows an
overlay of CD45 and CD11b expression of IFNβ/YFP+ (red) and IFNβ/YFP−
(grey) cells isolated from the brain of IFNβmob/mob mice on d17 after
immunization. c Quantification of IFNβ/YFP+ cells in the brain of IFNβmob/mob
mice on d17 after immunization. Error bars represent SEM. d Mononuclear
cells from the spinal cord of naïve WT and IFNβmob/mob mice were analyzed
by flow cytometry as shown in a. e Representative dot blot of an overlay of
CD45 and CD11b expression shows no IFNβ/YFP expressing cells under naïve
conditions.
Additional file 5: Figure S5. Impact of IFNβ on myelin phagocytosis. a
Histological analysis of LPC-demyelinated or untreated OSCs stainied with
anti-NF-M and anti-MBP antibodies. b Untreated microglia were labeled
with DiD (blue circles) and mixed (ratio 1:1) with CFSE labeled cells treated
with rIFNβ for 24 h (red circles) before transfer onto LPC-demyelinated OSCs.
For better visualization transplanted BV2 cells were marked using Adobe
Photoshop software. c Quantification of myelin associated BV2 cells from
(b). Diagram shows percentages of IFNβ-treated (red bars) and control (blue
bars) BV2 cells associated with myelin debris. (n = 4). d qRT-PCR for genes
involved in the phagocytic process in WT, IFNβ−/− and IFNAR1−/− primary
adult microglia stimulated with rIFNβ (24 h). (n = 2-4). e Expression of genes
involved in the phagocytic process in BV2 microglia upon IFNβ
treatment. Cells were stimulated as in (d). (n = 3). f Immunofluorescent
staining of primary adult microglia after incubation with DII-labeled myelin
for 2 h. Cells were stained with anti-Iba1, anti-LAMP2 and anti-MBP
antibodies for fluorescent microscopy. g qRT-PCR analysis of Isg56-gene
expression in WT, IFNβ−/− and IFNAR1−/− primary microglia treated with
rIFNβ (6 h, 24 h). h and i Uptake of DII-labeled myelin by BV2 cells in
response to rIFNβ. BV2 cells were 24 h pre-treated with rIFNβ and
incubated with DII-labeled myelin for 1 h. h Quantification of BV2 cells
co-localized with DII-myelin. (n = 6). i BV2 cells were stained for Iba1
and Hoechst. j and k Quantitative analysis of myelin debris in demyelinated
OSCs of IFNβ+/+ and IFNβ−/− mice. Demyelination was induced as in (a) and
production of IFNβ induced with poly (I:C). On d6 MBP intensity was
analyzed using ImageJ software. (n = 3). Error bars represent SEM. Scale bars
represent 50 μm (f,i), 100 μm (a,b),1 mm (j).
Additional file 6: Figure S6. Scoring table for myelin debris quantification.
OSCs were prepared as described and demyelinated by LPC treatment. OSCs
were further processed for MBP-staining. The scoring scheme represents the
amount of myelin debris in 0.1 mm2 in OSCs stained for MBP. A score of “0”
points to no visible myelin debris and score “3” displays an area covered with
myelin debris (indicated by arrows). Scale bar represents 100 μm.Competing interests
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